-+ 0.00%
-+ 0.00%
-+ 0.00%

XORTX THERAPEUTICS: SUBMITTED TYPE C MEETING REQUEST WITH FDA FOR XRX-026 PROGRAM FOR TREATMENT OF GOUT

Reuters·02/24/2025 12:02:22

Please log in to view news